BI Asset Management Fondsmaeglerselskab’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.12M Buy
90,266
+17,591
+24% +$1.82M 0.07% 211
2026
Q1
$7.03M Buy
+72,675
New +$7.45M 0.07% 202
2025
Q3
Sell
-510
Closed -$63K 727
2025
Q2
$63K Hold
510
﹤0.01% 661
2025
Q1
$52K Sell
510
-44,536
-99% -$4.35M ﹤0.01% 786
2024
Q4
$4.16M Buy
+45,046
New +$4.42M 0.04% 248
2024
Q1
Sell
-976
Closed -$65K 745
2023
Q4
$65K Hold
976
﹤0.01% 709
2023
Q3
$66K Buy
+976
New +$67.1K ﹤0.01% 687
2019
Q4
Sell
-35,191
Closed -$1.77M 354
2019
Q3
$1.77M Buy
+35,191
New +$1.77M 0.09% 178

Other funds holding EHC

BI Asset Management Fondsmaeglerselskab's EHC Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Encompass Health (EHC) stake by 24% in Q2 2026, buying an estimated $1.82M and bringing the position to 90,266 shares worth $9.12M. The position accounts for 0.07% of the portfolio, ranked #211.

BI Asset Management Fondsmaeglerselskab first reported a position in EHC in Q3 2019 and has held it in 8 quarters since. 341 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 90,266 shares of Encompass Health worth $9.12M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 17,591 Encompass Health shares in Q2 2026, an estimated $1.82M.
  • Encompass Health made up 0.07% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #211 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Encompass Health in Q3 2019 and has held it in 8 quarters since.
  • 341 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.